A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 31/70 (2006.01) C12N 9/14 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2217967
A method for regulating in vivo calcium transport in cardiac muscle of animals suffering from congestive heart failure is disclosed. According to the method, calcium ATPase activity (which decreases as congestive heart failure develops) and cardiac muscle contractility augmented by delivering a gene which operatively encodes the enzyme into the heart. Delivery systems (including recombinant expression vectors) are provided, as are methods for monitoring the expression and effect of the gene product on cardiac performance.
Ce procédé permet de moduler in vivo le transport du calcium dans le muscle cardiaque d'animaux souffrant de défaillance cardiaque congestive. Il consiste à accroître l'activité de la calcium ATPase (qui diminue quand une défaillance cardiaque congestive survient) et la contractilité du muscle cardiaque par l'apport d'un gène qui code effectivement cette enzyme à destination du coeur. On décrit des vecteurs de libération (y compris des vecteurs d'expression recombinés), ainsi que des procédés permettant de contrôler l'expression d'un tel produit génique et son effet sur le rendement du coeur.
Dillmann Wolfgang H.
Giordano Frank
Mestril Ruben
Mbm Intellectual Property Law Llp
The Regents Of The University Of California
LandOfFree
Augmentation in serca2 mediated calcium ion transport for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Augmentation in serca2 mediated calcium ion transport for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Augmentation in serca2 mediated calcium ion transport for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1713969